“…In all the studies included, improvements were observed between early and late-experience stages [ 7 , 11 – 43 ]. Among the evaluated variables, the following improvements were noted: the endocrinological cure rate (EC) showed improvement in all 7 articles out of 7 evaluated [ 13 , 16 , 18 , 21 , 24 , 30 , 33 ], operative time (OT) improved in 11 out of 12 articles (91%) [ 13 , 14 , 16 , 17 , 22 , 29 , 32 , 34 – 36 , 38 ], postoperative cerebrospinal fluid leak (CSF) improved in 23 out of 28 articles (82%) [ 12 , 15 , 17 , 19 , 20 , 22 , 23 , 25 , 27 – 29 , 31 – 35 , 37 – 43 ], visual improvement was observed in 9 out of 12 articles (75%) [ 13 , 14 , 16 , 22 , 28 , 31 , 34 , 37 , 41 ], gross total resection (GTR) improved in 14 out of 21 articles (67%) [ 7 , 13 , 14 , 19 , 21 , 22 , 26 – 30 , 38 – 40 ], hospital length of stay (LOS) decreased in five out of 10 studies (50%) [ 11 , 12 , 16 , 17 , 22 ], and postoperative diabetes insipidus (DI) decreased in 7 out of 15 articles (47%) [ 3 , 14 , 16 , 17 , ...…”